Following key FDA approval, St. Louis medtech startup SentiAR raises $5.1M

SentiAR ’s new funding follows its receipt of 510(k) clearance from the U.S. Food and Drug Administration for its CommandEP system, which provides physicians with a holographic guidance system for invasive cardiac procedures.

Source: bizjournals.com Health Care:Physician Practices headlines - April 13, 2021 Category: American Health Authors: Nathan Rubbelke Source Type: news